Monte Rosa Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
20 Sep 24 | SellUS$7,395,203 | Versant Venture Management, LLC | Company | 1,132,566 | US$6.53 | |
13 Sep 24 | SellUS$3,404,791 | Versant Venture Management, LLC | Company | 567,213 | US$6.16 | |
05 Jul 24 | SellUS$6,166 | Edmund Dunn | Individual | 1,610 | US$3.83 | |
03 Jun 24 | SellUS$4,876 | Edmund Dunn | Individual | 1,207 | US$4.04 |
Insider Trading Volume
Insider Buying: GLUE insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 430,482 | 0.701% |
General Public | 7,805,953 | 12.7% |
Hedge Funds | 9,451,095 | 15.4% |
VC/PE Firms | 14,889,572 | 24.3% |
Institutions | 28,790,407 | 46.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 23.6%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,692,298 | US$41.2m | 0% | 2.13% | |||
7,197,274 | US$38.6m | -19.1% | 15.52% | |||
5,977,587 | US$32.0m | 17.3% | no data | |||
5,094,974 | US$27.3m | -4.6% | no data | |||
4,916,095 | US$26.4m | 0% | 0.22% | |||
4,535,000 | US$24.3m | 0% | 0.33% | |||
2,659,000 | US$14.3m | 0% | 0.57% | |||
2,547,075 | US$13.7m | 55.7% | no data | |||
2,360,093 | US$12.7m | 2.3% | no data | |||
1,472,331 | US$7.9m | 0% | 3.45% | |||
1,464,015 | US$7.8m | 0% | 0.57% | |||
995,943 | US$5.3m | 1.6% | 0.01% | |||
890,000 | US$4.8m | 0% | 0.34% | |||
847,442 | US$4.5m | 15.2% | no data | |||
636,084 | US$3.4m | 3.39% | no data | |||
416,538 | US$2.2m | 0% | no data | |||
375,000 | US$2.0m | 0% | 0.32% | |||
311,800 | US$1.7m | 24.4% | no data | |||
307,319 | US$1.6m | 15.9% | 0.02% | |||
294,196 | US$1.6m | 1.29% | no data | |||
261,014 | US$1.4m | -48.9% | 0.1% | |||
254,714 | US$1.4m | 109% | no data | |||
193,696 | US$1.0m | 0.27% | no data | |||
166,671 | US$893.3k | 38.2% | no data | |||
153,758 | US$824.1k | 112% | no data |